Gene therapy for renal anemia in mice with polycystic kidney using an adenovirus vector encoding the human erythropoietin gene
- 1 April 1999
- journal article
- Published by Elsevier in Kidney International
- Vol. 55 (4) , 1234-1240
- https://doi.org/10.1046/j.1523-1755.1999.00381.x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- The Intensity of Hemodialysis and the Response to Erythropoietin in Patients with End-Stage Renal DiseaseNew England Journal of Medicine, 1996
- Sustained delivery of erythropoietin in mice by genetically modified skin fibroblasts.Proceedings of the National Academy of Sciences, 1995
- Myoblast transfer of human erythropoietin gene in a mouse model of renal failure.Journal of Clinical Investigation, 1995
- Stimulation of erythropoiesis by in vivo gene therapy: physiologic consequences of transfer of the human erythropoietin gene to experimental animals using an adenovirus vectorBlood, 1994
- Erythropoietin Gene Transfer and Expression in Adult Normal Mice: Use of an Adenovirus VectorHuman Gene Therapy, 1994
- The molecular mechanism of erythropoietin actionEuropean Journal of Biochemistry, 1992
- ErythropoietinNew England Journal of Medicine, 1991
- Treatment of the Anemia of Progressive Renal Failure with Recombinant Human ErythropoietinNew England Journal of Medicine, 1989
- Localization of erythropoietin synthesizing cells in murine kidneys by in situ hybridizationBlood, 1988
- On the Mechanism of Erythropoietin-induced DifferentiationJournal of Biological Chemistry, 1974